JNJ-9414
/ J&J
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
July 18, 2025
A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants
(clinicaltrials.gov)
- P1 | N=15 | Active, not recruiting | Sponsor: Janssen Research & Development, LLC | Trial completion date: Jun 2037 ➔ Oct 2037 | Trial primary completion date: Jun 2025 ➔ Oct 2037
Trial completion date • Trial primary completion date • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
August 14, 2024
A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants
(clinicaltrials.gov)
- P1 | N=15 | Active, not recruiting | Sponsor: Janssen Research & Development, LLC | Trial primary completion date: Jul 2024 ➔ Jun 2025
CAR T-Cell Therapy • Metastases • Trial primary completion date • Genito-urinary Cancer • Metastatic Castration-Resistant Prostate Cancer • Oncology • Prostate Cancer • Solid Tumor
May 03, 2023
A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants
(clinicaltrials.gov)
- P1 | N=15 | Active, not recruiting | Sponsor: Janssen Research & Development, LLC | Trial completion date: Dec 2025 ➔ Jun 2037
Trial completion date • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
February 15, 2023
A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants
(clinicaltrials.gov)
- P1 | N=15 | Active, not recruiting | Sponsor: Janssen Research & Development, LLC | Recruiting ➔ Active, not recruiting | N=40 ➔ 15
CAR T-Cell Therapy • Enrollment change • Enrollment closed • Metastases • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
October 26, 2022
A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants
(clinicaltrials.gov)
- P1 | N=40 | Recruiting | Sponsor: Janssen Research & Development, LLC | N=60 ➔ 40
CAR T-Cell Therapy • Enrollment change • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
August 03, 2022
A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants
(clinicaltrials.gov)
- P1 | N=60 | Recruiting | Sponsor: Janssen Research & Development, LLC | Trial completion date: Dec 2024 ➔ Dec 2025
Trial completion date • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
1 to 6
Of
6
Go to page
1